sub:assertion {
d:DB01007 v:identifier "DB01007" ;
v:namespace "drugbank" ;
v:uri "http://bio2rdf.org/drugbank:DB01007" ;
v:x-identifiers.org <
http://identifiers.org/drugbank/DB01007> ;
dv:drugbank-id "APRD01262" , "DB01007" ;
dv:x-atc <
http://bio2rdf.org/atc:D01AC07> ;
dv:x-cas <
http://bio2rdf.org/cas:65899-73-2> ;
dv:x-chemspider <
http://bio2rdf.org/chemspider:5282> ;
dv:x-dpd <
http://bio2rdf.org/dpd:2217406> ;
dv:x-kegg <
http://bio2rdf.org/kegg:C08082> , <
http://bio2rdf.org/kegg:D00890> ;
dv:x-ndc <
http://bio2rdf.org/ndc:24385-374-82> ;
dv:x-pharmgkb <
http://bio2rdf.org/pharmgkb:PA164746156> ;
dv:x-pubchemcompound <
http://bio2rdf.org/pubchem.compound:5482> ;
dv:x-pubchemsubstance <
http://bio2rdf.org/pubchem.substance:46508604> ;
dv:x-wikipedia <
http://bio2rdf.org/wikipedia:Tioconazole> ;
dct:description "Tioconazole is an antifungal medication of the Imidazole class used to treat infections caused by a fungus or yeast. Tioconazole topical (skin) preparations are also available for ringworm, jock itch, athlete's foot, and tinea versicolor or \"sun fungus\". Tioconazole interacts with 14-alpha demethylase, a cytochrome P-450 enzyme that converts lanosterol to ergosterol, an essential component of the yeast membrane. In this way, tioconazole inhibits ergosterol synthesis, resulting in increased cellular permeability."@en ;
dct:identifier "drugbank:DB01007" ;
dct:title "Tioconazole"@en ;
a dv:Drug ;
rdfs:label "Tioconazole [drugbank:DB01007]"@en ;
rdfs:seeAlso <
http://www.drugbank.ca/drugs/DB01007> , <
http://www.drugs.com/cdi/tioconazole.html> , <
http://www.rxlist.com/cgi/generic3/tioconaz.htm> .
}